Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
grade F 5.35 1.52% 0.08
MYOV closed up 1.52 percent on Tuesday, October 15, 2019, on 1.86 times normal volume.

Earnings due: Nov 6

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical MYOV trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
20 DMA Resistance Bearish 1.52%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.52%

Older signals for MYOV ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Chemistry Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Pyrimidines Gnrh Antagonists Gonadotropin Releasing Hormone Antagonist Roivant Sciences Uterine Fibroids
Is MYOV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.02
52 Week Low 4.57
Average Volume 357,381
200-Day Moving Average 13.6673
50-Day Moving Average 6.5199
20-Day Moving Average 5.2475
10-Day Moving Average 4.936
Average True Range 0.4058
ADX 43.3
+DI 19.9088
-DI 19.4003
Chandelier Exit (Long, 3 ATRs ) 5.1026
Chandelier Exit (Short, 3 ATRs ) 5.7874
Upper Bollinger Band 6.1474
Lower Bollinger Band 4.3476
Percent B (%b) 0.56
BandWidth 34.298237
MACD Line -0.4627
MACD Signal Line -0.5661
MACD Histogram 0.1034
Fundamentals Value
Market Cap 325.52 Million
Num Shares 60.8 Million
EPS -1.63
Price-to-Earnings (P/E) Ratio -3.28
Price-to-Sales 0.00
Price-to-Book 5.51
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.10
Resistance 3 (R3) 6.13 5.91 5.98
Resistance 2 (R2) 5.91 5.72 5.90 5.93
Resistance 1 (R1) 5.63 5.60 5.77 5.60 5.89
Pivot Point 5.41 5.41 5.48 5.40 5.41
Support 1 (S1) 5.13 5.22 5.27 5.10 4.81
Support 2 (S2) 4.91 5.10 4.90 4.77
Support 3 (S3) 4.63 4.91 4.73
Support 4 (S4) 4.60